MIF and nasopharyngeal carcinoma: The results showed higher expression of MIF in NPC patients vs. normal controls and higher expression in clinical stage III-IV NPC patients than in clinical stage I-II patients (Figures 1C,D), which suggested that the upregulation of MIF level may be closely related to end-stage nasopharyngeal carcinoma.